Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Clarus Therapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Clarus Therapeutics Holdings Inc market cap is $72,800.00.
What is the 52-week high for Clarus Therapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clarus Therapeutics Holdings Inc 52 week high is $3.94 as of October 10, 2025.
What is the 52-week low for Clarus Therapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clarus Therapeutics Holdings Inc 52 week low is $0.001 as of October 10, 2025.
What was Clarus Therapeutics Holdings Inc stock price yesterday?
Clarus Therapeutics Holdings Inc stock price yesterday was $0.0014.
What is the PE ratio of Clarus Therapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Clarus Therapeutics Holdings Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Clarus Therapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Clarus Therapeutics Holdings Inc P/B ratio is -0.0056.
What is the 50-day moving average of Clarus Therapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Clarus Therapeutics Holdings Inc 50-day moving average is $0.0066.
